Acute Intravenous Synaptamine Complex Variant KB220™ “Normalizes” Neurological Dysregulation in Patients during Protracted Abstinence from Alcohol and Opiates as Observed Using Quantitative Electroencephalographic and Genetic Analysis for Reward Polymorphisms: Part 1, Pilot Study with 2 Case Reports-Reference-Cited by-同舟云学术

Acute Intravenous Synaptamine Complex Variant KB220™ “Normalizes” Neurological Dysregulation in Patients during Protracted Abstinence from Alcohol and Opiates as Observed Using Quantitative Electroencephalographic and Genetic Analysis for Reward Polymorphisms: Part 1, Pilot Study with 2 Case Reports

Published:2010-11 Issue:6 Volume:122 Page:188-213
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Miller David K.,Bowirrat Abdalla,Manka Matthew,Miller Merlene,Stokes Stanley,Manka Debra,Allen Cameron,Gant Charles,Downs B. William,Smolen Andrew,Stevens Emily,Yeldandi Swetha,Blum Kenneth

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3810/pgm.2010.11.2236

Reference130 articles.

1. EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy, and Recommendations for Further Research

2. Synergy of Ethanol and Putative Neurotransmitters: Glycine and Serine

3. Enkephalinase inhibition: Regulation of ethanol intake in genetically predisposed mice

4. Evidence, Evidence-Based Medicine, and Evidence Utility in Psychiatry and Electrophysiology

5. Neurogenetic Deficits Caused by Alcoholism: Restoration by SAAVE™, a Neuronutrient Intervention Adjunct

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids;Journal of Personalized Medicine;2022-12-06

2. Why haven't we solved the addiction crisis?;Journal of the Neurological Sciences;2022-11

3. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?;Journal of Personalized Medicine;2022-10-14

4. DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis;Journal of Personalized Medicine;2022-08-30

5. Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases;Current Psychiatry Research and Reviews;2022-07